Videos and Podcasts
Pharmaxis Welcomes Green Light to Progress to Phase 2 Bone Marrow Cancer Trial
Pharmaxis CEO Gary Phillips speaks to Proactive Investors following the news the Company has been cleared to progress its bone marrow cancer trial to a phase 2 dose expansion phase. It follows further positive results of data analysis from the phase 1c clinical trial of its drug PXS‐5505.
Watch the interview here.
Recording of Pharmaxis Presentation at Biotech Webinar
Investors may view a recording of Pharmaxis Ltd chief executive officer Mr Gary Phillips' presentation at the Monsoon Communications and Peak Asset Management Biotech Webinar on Monday 27 September using the link below. The webinar also features presentations from Avita Medical, Biotron and Avecho Biotech.
Pharmaxis Hails Positive Results in Phase 1 Scarring Trial
Pharmaxis CEO Gary Phillips speaks to Proactive Investors following the news its novel topical drug treatment for scarring has delivered positive phase 1 clinical trial results and will now advance to the next stage of development in patients with established scars.
Watch the interview here.